Science Daily -
1 Oct 2018 17:02
In a proof-of-principle study, researchers report that a certain liver immune cell called a macrophage contains only defective or inert HIV-1 copies, and aren't likely to restart infection on their own in HIV-1-infected people on long-term antiretroviral therapy (ART).
Share this Article